Long term study of naproxen challenged by a short-term double blind cross-over study with placebo in rheumatoid patients.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D008738:Methyl Ethers; D009281:Naphthalenes; D010919:Placebos; D011422:Propionates